LITE 240920 57.50P (LITE240920P57500) Stock Options, News & Quotes

2.40
-0.85-26.15%

15min DelayClose Sep 13 16:00 ET

2.40High2.40Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Moomoo AI

Feb 23 05:17

Matthew Sepe's recent sale suggests he considered a lower price fair, questioning the higher valuation of shares. Despite significant insider ownership indicating alignment, the absence of insider purchases and history of sales call for caution before buying Lumentum Holdings shares.

Have Lumentum Holdings Insiders Been Selling Stock?

Moomoo AI

Feb 15 11:50

Despite Lumentum Holdings' recent revenue drop, the market may anticipate a reversal, justifying its high P/S ratio. The company's projected revenue growth, surpassing the Communications industry, could be maintaining share price and shareholder confidence.

The Price Is Right For Lumentum Holdings Inc. (NASDAQ:LITE)

Moomoo AI

Jan 25 10:26

The company's balance sheet is strained due to debt and EBIT level loss. Its use of debt is risky, given it burned through US$9.7m of cash last year.

Is Lumentum Holdings (NASDAQ:LITE) Using Too Much Debt?

Moomoo AI

Jan 4 10:18

Lumentum Holdings is being seen as a valuable investment opportunity due to its future outlook and the fact that it is being undervalued by the stock market. The optimistic growth projections have not yet been fully accounted for in the share price.

Should You Investigate Lumentum Holdings Inc. (NASDAQ:LITE) At US$49.95?

Moomoo AI

Dec 22, 2023 08:16

Bristol Myers may bolster its treatments portfolio with Karuna acquisition. Ansys' possible undervaluation hinted by takeover speculation. ASML's gear shipment to Intel viewed positively, fostering quicker semiconductor production. Lumentum's upgrade signals bullish prospects for 2024.

4 Stocks to Watch on Friday: Karuna Therapeutics on Bristol Myers Deal, Ansys and More

Semiconductor sector is surging: Opportunity or risk?